Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
The Journal of Biological Chemistry
|
August 26, 1994
Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A)
E C Kohn, W Jacobs, Y S Kim, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
July 1, 1990
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors
O M El-Badry, C Minniti, E C Kohn, et al.
Cancer Research
|
February 15, 1994
Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI
E C Kohn, C C Felder, W Jacobs, et al.
Investigational New Drugs
|
January 1, 1995
Cutaneous manifestations of Taxol therapy
C J Link, G A Sarosy, E C Kohn, et al.
Gynecologic Oncology
|
January 10, 2022
Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based review
S M Temkin, E Chapman-Davis, N Nair, et al.
Gynecologic Oncology
|
July 1, 1999
Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors
M R Brown, R Chuaqui, C D Vocke, et al.
Biochemical and Biophysical Research Communications
|
June 8, 2002
E-selectin modulates the malignant properties of T84 colon carcinoma cells
A M Flugy, M D'Amato, D Russo, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
September 15, 1999
Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: use of a single model for simultaneous determination of changing parameters
K S Bauer, E C Kohn, R M Lush, et al.
Cancer Research
|
December 16, 1998
An improved method for construction of directionally cloned cDNA libraries from microdissected cells
L A Peterson, M R Brown, A J Carlisle, et al.
British Journal of Cancer
|
January 7, 2010
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity
J-M Lee, G A Sarosy, C M Annunziata, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
The Journal of Biological Chemistry
|
August 26, 1994
Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A)
E C Kohn, W Jacobs, Y S Kim, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
July 1, 1990
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors
O M El-Badry, C Minniti, E C Kohn, et al.
Cancer Research
|
February 15, 1994
Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI
E C Kohn, C C Felder, W Jacobs, et al.
Investigational New Drugs
|
January 1, 1995
Cutaneous manifestations of Taxol therapy
C J Link, G A Sarosy, E C Kohn, et al.
Gynecologic Oncology
|
January 10, 2022
Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based review
S M Temkin, E Chapman-Davis, N Nair, et al.
Gynecologic Oncology
|
July 1, 1999
Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors
M R Brown, R Chuaqui, C D Vocke, et al.
Biochemical and Biophysical Research Communications
|
June 8, 2002
E-selectin modulates the malignant properties of T84 colon carcinoma cells
A M Flugy, M D'Amato, D Russo, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
September 15, 1999
Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: use of a single model for simultaneous determination of changing parameters
K S Bauer, E C Kohn, R M Lush, et al.
Cancer Research
|
December 16, 1998
An improved method for construction of directionally cloned cDNA libraries from microdissected cells
L A Peterson, M R Brown, A J Carlisle, et al.
British Journal of Cancer
|
January 7, 2010
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity
J-M Lee, G A Sarosy, C M Annunziata, et al.
Page
of 8